FDA Endorses Updated Labeling Featuring Boxed Warning for Immune Effector Cell-Associated Enterocolitis Post-Treatment with Ciltacabtagene Autoleucel (CARVYKTI, Janssen Biotech, Inc.)

FDA Endorses Updated Labeling Featuring Boxed Warning for Immune Effector Cell-Associated Enterocolitis Post-Treatment with Ciltacabtagene Autoleucel (CARVYKTI, Janssen Biotech, Inc.)

FDA Endorses Updated Labeling Featuring Boxed Warning for Immune Effector Cell-Associated Enterocolitis Post-Treatment with Ciltacabtagene Autoleucel (CARVYKTI, Janssen Biotech, Inc.)